A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an experimental CRISPR-based therapy. This incident places gene therapy under close scrutiny, raising critical questions about its safety and future. The results of these trials will shape the direction of genetic medicine and influence how […]
